saxenda glp 1 agonist First Generic GLP-1 Injection OK'd for Weight Loss Saxenda (Liraglutide) | Lifestyle Medical
Description
83% of patients saw significant improvement in their diseases compared to 18% on placebo
The oral drug also had a safety profile consistent with its injectable formulation
& Liu, D
Medical Writing and Editorial Assistance The authors would like to thank Dr
Rhea, E
[DOI] [PMC free article] [PubMed] [Google Scholar] 69
